20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Human Sef isoforms and methods of using same for cancer gene therapy
#5402Epad, an oocyte specific protein
#5403Method of preventing acute pulmonary cell injury
#5404Using heat shock proteins to increase immune response
#5405Diagnosis, prognosis and treatment of pulmonary diseases
#5406Therapeutic agent for hematopoietic tumors
#5407Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
#5408Therapeutic agents and methods for cardiovascular disease
#5409Inhibition of adhesion and migration of an endothelial cell to fibronectin by neutrophil alpha-defensins
#5410Nutritional compositions for nutritional management of patients with liver disease
#5411Apolipoprotein A1 mimetics and uses thereof
#5412Animal model for studying hormone signalling and method of modulating the signalling
#5413Detoxification depot for Alzheimer's disease
#5414Treatment of neurological deficits in the striatum or substanta nigra pars compacta
#5415Treatment of neurological deficits in the striatum or substanta nigra pars compacta
#5416Ocular gene therapy
#5417Methods to stimulate insulin production by pancreatic β-cells
#5418DRG11-responsive (DRAGON) gene and uses thereof
#5419Method for the production of protamine
#5420Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
#5421Prevention and treatment of synucleinopathic and amyloidogenic disease
#5422Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease
#5423Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
#5424Compositions for inducing of immunotolerance
#5425Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
#5426Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
#5427Method for remodeling bone and related sutures
#5428Controlled and directed local delivery of anti-inflammatory compositions
#5429Controlled and directed local delivery of anti-inflammatory compositions
#5430Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
#5431Novel use of aim 3 acting as a tumor suppressor
#5432Methods for modulating angiogenesis and apoptosis with apelin compositions
#5433XAF genes and polypeptides: methods and reagents for modulating apoptosis
#5434IL-1 antagonist formulations
#5435IGF-1 receptor interacting proteins
#5436Milk protein isolate and method for preparing same
#5437Modified defensins and their use
#5438Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair
#5439Methods and composition for modulating type I muscle formation using pgc-1 alpha
#5440Compositions and methods for the treatment or prevention of gallbladder disease
#5441Use of galectin-3 and galectin-7 to promote the re-epithelialization of wounds
#5442Method and composition for inhibiting or slowing blood coagulation
#5443Prevention and treatment of amyloidogenic disease
#5444Method for preparation of vesicles loaded with biological material and different uses thereof
#5445Prevention and treatment of amyloidogenic disease
#5446Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
#5447Compositions and methods for treatment of lymphatic and venous vessel arterialization
#5448Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments
#5449Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
#5450Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids
#5451GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same
#5452Methods for magnetic resonance imaging
#5453Vascular targets for detecting, imaging and treating neoplasia or neovasculature
#5454Method to modulate the immune system with a novel guanine nucleotide exchange factor
#5455Peptide composition
#5456Autologous coatings for implants
#5457Apoprotein cochleate compositions
#5458Intradiscal anti-inflammatory therapy involving autologous adiponectin
#5459Controlled delivery of therapeutic compounds
#5460Methods of using non-human animal Apoliprotein A-I protein
#5461Methods of inhibiting tumor cell proliferation
#5462CXCR4 antagonist treatment of hematopoietic cells
#5463Modification of feeding behavior using PYY and GLP-1
#5464Tumor specific oligosaccharide epitopes and use thereof
#5465Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#5466Anticancer agent
#5467Modulation of stem cell differentiation by modulation of caspase-3 activity
#5468Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators
#5469Use of ingap for reversing diabetes
#5470Treatment of conditions involving demyelination
#5471Use of gelsolin to treat infections
#5472Methods of suppressing microglial activation
#5473Methods for treating and preventing microbial infections
#5474Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
#5475Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
#5476Use of PTHrP antagonists for treating renal cell carcinoma
#5477Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#5478Treatment of complement-associated disorders
#5479Wound healing dressing for enhancing fibrocyte formation
#5480Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
#5481Methods for enhancing the bioavailability of a drug
#5482Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
#5483Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
#5484ProapolipoproteinA-I mutant and pharmaceutical composition comprising the same for prevention and treatment of atherosclerosis and hyperlipidemia
#5485Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
#5486Caspase 3 inhibitors
#5487TCL-1b gene and protein and related methods and compositions
#5488Assay for TSG101 as inhibitors of HIV production
#5489The p65 subunit of nf-kb for the radiosensitization of cells
#5490Method for the treatment of hearing loss
#5491Treatment for dark adaptation
#5492Compositions and methods for preventing or treating cancer
#5493Methods and compositions for regulating protein-protein interactions
#5494CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
#5495Use of C-reactive protein to treat immune complex-mediated renal disease
#5496Therapeutic uses of Reg protein
#5497Methods and active substances for protecting organs
#5498Removal of serum albumin from human serum or plasma
#5499Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma
#5500Compositions and methods for diagnosis and therapy of cancers
#5501Inhibition of bright function as a treatment for excessive immunoglobulin production
#5502Compounds which modulate amyloidogenesis and methods for their identification and use
#5503Methods and compositions for modulating and detecting activin dimer and dimer formation
#5504Nanogene therapy for cell proliferation disorders
#5505Neutralizing antibodies and methods of use thereof
#5506F11 receptor (F11R) antagonists as therapeutic agents
#5507Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
#5508Therapeutic chemokine receptor antagonists
#5509Nucleic acid sequences and proteins involved in cellular senescence
#5510Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells
#5511NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#5512Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#5513Therapeutic proteins
#5514Method for treating glaucoma
#5515Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
#5516Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
#5517Recombinant mutants of rhabdovirus and methods of use thereof
#5518Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
#5519Materials and methods for treating vascular leakage in the eye
#5520Transgenic non-human animals expressing a truncated activin type II receptor
#5521Methods and compositions for treatment of neurological disorder
#5522Gastrointestinal proliferative factor and uses thereof
#5523Gastrointestinal proliferative factor and uses thereof
#5524Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
#5525Quorum sensing and biofilm formation
#5526Prevention and treatment of amyloidogenic disease
#5527Use of an inhibitor or antagonist against tissue factor
#5528Use of immunomodulating agents
#5529Compositions and methods for inhibiting cell proliferation
#5530Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals
#5531Prevention and treatment of amyloidogenic disease
#5532Humanized antibodies that recognize beta amyloid peptide
#5533Synergistic effect of the osteogenic growth peptide and the granulocyte clony stimulating factor on haematogenesis
#5534Proliferation- and differentiation-modulating agents and uses therefor
#5535Peptides selectively lethal to malignant and transformed mammalian cells
#5536Method of screening a compound for anxiolytic activity in an apolipoprotein E knockout animal
#5537Materials for the delivery of biologically-active material to cells
#5538Oxygenated dibenzo-alpha-pyrone chromoproteins
#5539Modulators of paraptosis and related methods
#5540Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, Bcl-xand Bcl-w, and uses thereof
#5541Method and composition for regulating activity of regulatory T cells
#5542Method for preventing mineralization in the periodontal ligament (PDL)
#5543Substances for preventing and treating autoimmune diseases
#5544Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
#5545Anticancer peptide compositions
#5546Remedy for infections
#5547GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
#5548Methods and compositions based on protein interactions with mastermind
#5549Methods of suppressing fibrosis and fibrocyte formation
#5550Method of inhibiting collagen formation by VDUP1 inhibition
#5551Compositions, systems, and methods for focusing a cell-mediated immune response
#5552Methods and compositions for inhibiting c-met dimerization and activation
#5553Use of resistin to treat hematopoietic disorders
#5554Compositions and methods for cleaving IAP
#5555Composition for stabilizing corneal tissue during or after orthokeratology lens wear
#5556Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
#5557Gene products differentially expressed in cancerous cells and their methods of use II
#5558Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
#5559Modulation of complement to treat pain
#5560Methods and products based on oligomerization of stress proteins
#5561Modulators of the Notch signalling pathway and uses thereof in medical treatment
#5562Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
#5563Method for inhibiting jnk-1 kinase activity by SCCA
#5564PSMA formulations and uses thereof
#5565Multimeric Apo A-I agonist compounds
#5566Methods of inducing IL-10 production
#5567Binding agents for cd44 glycoproteins and methods of use
#5568Composition for promoting development of nervous system
#5569Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
#5570IGF-binding protein-derived peptide or small molecule
#5571Polypeptoid pulmonary surfactants
#5572Use of peptides
#5573Methods of controlling axonal growth
#5574Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
#5575Methods and reagents for diagnosis and treatment of diabetes
#5576Treatment of rheumatoid arthritis with FLIP antagonists
#5577Methods and systems for treatment of neurological diseases of the central nervous system
#5578Treatment of autoimmune diseases by oral administration of autoantigens
#5579Methods and compositions for regeneration of aged skeletal muscle tissues
#5580Tumor treating composition and methods
#5581Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
#5582Composition and methods for modulating CNS activity
#5583Methods for inhibiting vascular permeability
#5584Tenascin-W compositions and uses thereof
#5585Use of neglected target tissue antigens in modulation of immune responses
#5586Family of cystatin-related chemoattractant proteins
#5587Methods and compositions related to neuronal differentiation
#5588DNA vaccines encoding heat shock proteins
#5589Modified annexin proteins, and methods and compositions for using them
#5590Methods for affecting body composition
#5591Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
#5592Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#5593Positive modulator of bone morphogenic protein-2
#5594Prevention and treatment of amyloidogenic disease
#5595Compositions and methods for the systemic treatment of arthritis
#5596Methods for treating Parkinson's disease
#5597Methods and compositions related to plunc polypeptides
#5598Eosinophil Major Basic Protein as a natural heparanase-inhibiting protein, compositions, methods and uses thereof
#5599Prevention and treatment of amyloidogenic disease
#5600Prevention and treatment of amyloidogenic disease
#5601Methods of treating various cancers using melanoma differentiation associated protein-7
#5602Methods and compositions for modulating adipocyte function
#5603RTVP based compositions and methods for the treatment of prostate cancer, autoimmunity and infectious disease
#5604Pharmaceuticals and methods for treating hypoxia and screening methods therefor
#5605Method for the production of transgenic proteins useful in the treatment of obesity and diabetes
#5606Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure
#5607Paralytic peptide for use in neuromuscular therapy
#5608Treatment of shock using adrenomedullin binding protein-1
#5609Extracellular TNF inhibitors for treating CNS disorders
#5610Endophilin homologous proteins involved in the regulation of energy homeostasis
#5611Non-invasive treatment of disease using amphipathic compounds
#5612High-density lipoprotein coated medical devices
#5613Methods and agents for enhancing bone formation or preventing bone loss
#5614Methods and compositions for modulating beta-catenin phosphorylation
#5615Treatment and diagnosis of insulin-resistant states
#5616Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
#5617Methods of treating autoimmune diseases comprising administering CXCR4 antagonists
#5618Prevention and treatment of amyloidogenic disease
#5619Tissue adhesion formation control
#5620Integrin binding motif containing peptides and methods of treating skeletal diseases
#5621JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
#5622Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers
#5623Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
#5624Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#5625Treating abdominal pain due to pancreatitis with seaprose
#5626Methods of organ regeneration using -expressing pluripotent cells
#5627Signal peptide-containing molecules
#5628Method of analyzing gene expression
#5629Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#5630Compositions and methods for treating female fertility
#5631Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof
#5632Method and composition for treatment of angiogenesis
#5633Cysteine protease inhibitor
#5634Dopaminergic stimulatory factor
#5635Regulation of cell migration and adhesion
#5636EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders
#5637Vitamin d upregulated protein 1 (vdup-) methods and uses thereof
#5638Novel remedies for neurodegenerative disease
#5639Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
#5640Prevention and treatment of amyloidogenic disease
#5641Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
#5642Use of repeat sequence protein polymers in personal care compositions
#5643Method of treating allergen induced airway disease
#5644Composition for the therapy of diabetes mellitus and adiposity
#5645Metallothionein based neuronal therapeutic and therapeutic methods
#5646Child's cleaning implement comprising a biological extract
#5647Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#5648Type1 diabetes diagnostics and therapeutics
#5649Methods of diagnosis and treatment of interstitial lung disease
#5650Body weight gain inhibitor
#5651Biological inhibitions induced by contact inhibitory factor
#5652Anti-hiv agent
#5653Liposomes for protection against toxic compounds
#5654Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases
#5655Use NF-B inhibition in combination therapy for cancer
#5656Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors
#5657Hydrophobically-modified protein compositions and methods
#5658Inositol 1, 4, 5-triphosphate receptor (type 1), phosphorylation and modulation by CDC2
#5659Antitumor effect of mutant Bik
#5660Drug for regenerating tissue and vessel and method therefor
#5661Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#5662Specific markers for metabolic syndrome
#5663Methods of modulating lipid metabolism and storage
#5664Pseudotyped viruses and methods for their use
#5665Methods for inhibiting vascular permeability
#5666GASP1: a follistatin domain containing protein
#5667Regulation of matrix metalloproteinases by PSP94 family members
#5668Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators
#5669Inhibitors of PACE4 for the treatment of arthritis
#5670Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
#5671Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#5672Method to control tumor progression and invasiveness
#5673Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#5674Human α synuclein expressing transgenic mice
#5675Boroproline compound combination therapy
#5676Methods of inhibiting osteoclast activity
#5677Method and composition for the treatment of adenoviral ocular infections
#5678Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
#5679Compositions and methods for modulating serum cholesterol
#5680Human skin equivalents expressing exogenous polypeptides
#5681Methods for diagnosing and treating neoplasias using nf-at transcriptions factors
#5682Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
#5683Compositions of beta-defensin inducing agents
#5684Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases
#5685Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity
#5686Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease
#5687Remedies for metabolic bone diseases
#5688Osteoclast secreted chemokine and uses thereof
#5689Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
#5690Methods of controlling proliferation of cancer cells and cell death
#5691TGF-beta activation and use
#5692C-jun phosphorylation inhibitors
#5693Interleukin-18 binding proteins, their preparation and use
#5694Systemic viral/ligand gene delivery system and gene therapy
#5695Prevention and treatment of amyloidogenic disease
#5696Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
#5697Modulating response to genotoxic stress
#5698Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
#5699Prevention and treatment of amyloidogenic disease
#5700Modified IL-4 mutein receptor antagonists